NCT00803673View on ClinicalTrials.gov

A Healthy Volunteer Study With Inhaled GSK573719 and Placebo

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 5, 2008

Primary Completion Date

October 16, 2008

Study Completion Date

October 16, 2008

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

100mcg

100mcg '719

DRUG

500mcg

500mcg '719

DRUG

1000mcg

1000mcg '719

DRUG

Placebo

Placebo '719

Trial Locations (1)

2060

GSK Investigational Site, Antwerp

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY